Author

Maya G. Cappellino

The University of Texas MD Anderson Cancer CenterORCID 0009-0001-6592-0938Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 1

Frequent Co-Authors

Cara Guernsey-BiddleiD· 2 shared Kendra S. CarmoniD· 2 shared Peyton C. HighiD· 2 shared Sean P. SullivaniD· 2 shared Adela M. Aldana· 1 shared Li LiiD· 1 shared Sheng PaniD· 1 shared Shraddha SubramanianiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Cara Guernsey-BiddleORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintOct 18, 2026

Antibody-drug conjugate combination therapy targeting LGR5 and MET with different payloads enhances efficacy in preclinical colorectal cancer models

Shraddha Subramanian, Peyton C. High, Cara Guernsey-Biddle…·Kendra S. Carmon

This study shows that combining LGR5 and MET-targeting antibody-drug conjugates with different payloads improves efficacy and delays tumor relapse in colorectal cancer models.

DOI 10.64898/2026.07.18.739355

humanexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJun 23, 2026

Bispecific antibody-drug conjugates targeting EGFR and LGR5 exert potent antitumor activity in colorectal cancer models

Peyton C. High, Maya G. Cappellino, Sean P. Sullivan…·Kendra S. Carmon

EGFR:LGR5 bispecific antibody-drug conjugates show strong antitumor effects and outperform other ADCs in colorectal cancer models.

1 citation

humanproteomics

𝕏 PostBluesky